Mirae Asset Global Investments Co., Ltd. Biogen Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 42,705 shares of BIIB stock, worth $6.74 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

42,705

Previous 35,195 21.34%

Holding current value

$6.74 Million

Previous $8.16 Million 1.46%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$189.07 - $236.8 $1.42 Million - $1.78 Million	7,510 Added 21.34%	42,705 $8.28 Million
Q2 2024 Jul 30, 2024	SELL	$190.52 - $236.72 $22.7 Million - $28.2 Million	-119,133 Reduced 77.19%	35,195 $8.16 Million
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $1.36 Million - $1.71 Million	-6,396 Reduced 3.98%	154,328 $33.3 Million
Q4 2023 Jan 24, 2024	SELL	$222.59 - $267.94 $827,812 - $996,468	-3,719 Reduced 2.26%	160,724 $41.6 Million
Q3 2023 Oct 26, 2023	BUY	$253.3 - $285.89 $5.9 Million - $6.66 Million	23,282 Added 16.49%	164,443 $42.3 Million
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $1.44 Million - $1.66 Million	-5,224 Reduced 3.57%	141,161 $40.2 Million
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $11.1 Million - $12.6 Million	-43,106 Reduced 22.75%	146,385 $40.7 Million
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $2 Million - $2.43 Million	7,932 Added 4.37%	189,491 $52.5 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $4.49 Million - $6.19 Million	23,060 Added 14.55%	181,559 $48.5 Million
Q2 2022 Jul 26, 2022	BUY	$187.54 - $223.02 $5.33 Million - $6.34 Million	28,439 Added 21.87%	158,499 $32.3 Million
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $4.97 Million - $6.27 Million	25,663 Added 24.58%	130,060 $27.4 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $4.18 Million - $5.37 Million	18,669 Added 21.78%	104,397 $25 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $4.66 Million - $6.07 Million	16,459 Added 23.76%	85,728 $24.3 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $4.15 Million - $6.64 Million	16,014 Added 30.07%	69,269 $24 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $5.94 Million - $6.96 Million	-24,445 Reduced 31.46%	53,255 $14.9 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $2.41 Million - $3.63 Million	10,217 Added 15.14%	77,700 $19 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $2.26 Million - $2.61 Million	8,524 Added 14.46%	67,483 $19.1 Million
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $1.24 Million - $1.64 Million	4,798 Added 8.86%	58,959 $15.8 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $2.66 Million - $3.37 Million	9,895 Added 22.35%	54,161 $17.1 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $1.44 Million - $1.99 Million	6,534 Added 17.32%	44,266 $13.1 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $371,822 - $417,034	1,710 Added 4.75%	37,732 $8.79 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $772,997 - $852,063	3,525 Added 10.85%	36,022 $8.49 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $534,623 - $836,214	2,467 Added 8.22%	32,497 $7.65 Million
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $694,579 - $879,758	2,494 Added 9.06%	30,030 $9.04 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $637,797 - $834,062	-2,173 Reduced 7.31%	27,536 $9.75 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $332,715 - $396,527	1,292 Added 4.55%	29,709 $8.61 Million
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $1.18 Million - $1.67 Million	4,539 Added 19.01%	28,417 $7.78 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $645,736 - $723,273	2,099 Added 9.64%	23,878 $7.61 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $1.02 Million - $1.19 Million	3,617 Added 19.92%	21,779 $6.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,162	18,162 $4.93 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Biogen Inc. Transaction History